☰

Alan D. T. Barrett - Publications

Affiliations: 
University of Texas Medical Branch, Galveston, TX 
Area:
Pathology, Microbiology Biology
Website:
https://www.utmb.edu/pathology/faculty-directory/alan-d-barrett-phd
Tree Info Similar researchers PubMed Report error

187 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Thomas SJ, Barrett A. Zika vaccine pre-clinical and clinical data review with perspectives on the future development. Human Vaccines & Immunotherapeutics. 1-13. PMID 32702260 DOI: 10.1080/21645515.2020.1730657  0.352
2018 Wilder-Smith A, Hombach J, Ferguson N, Selgelid M, O'Brien K, Vannice K, Barrett A, Ferdinand E, Flasche S, Guzman M, Novaes HM, Ng LC, Smith PG, Tharmaphornpilas P, Yoon IK, et al. Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine. The Lancet. Infectious Diseases. PMID 30195995 DOI: 10.1016/S1473-3099(18)30494-8  0.316
2018 Reece LM, Beasley DW, Milligan GN, Sarathy VV, Barrett AD. Current status of Severe Fever with Thrombocytopenia Syndrome vaccine development. Current Opinion in Virology. 29: 72-78. PMID 29642053 DOI: 10.1016/J.Coviro.2018.03.005  0.327
2018 Luo H, Winkelmann ER, Fernandez-Salas I, Li L, Mayer SV, Daniz-Lozano R, Sanchez-Casas RM, Vasilakis N, Tesh R, Barrett AD, Weaver SC, Wang T. Zika, dengue and yellow fever viruses induce differential anti-viral immune responses in human monocytic and first trimester trophoblast cells. Antiviral Research. PMID 29331320 DOI: 10.1016/J.Antiviral.2018.01.003  0.31
2017 Shan C, Muruato AE, Jagger BW, Richner J, Nunes BTD, Medeiros DBA, Xie X, Nunes JGC, Morabito KM, Kong WP, Pierson TC, Barrett AD, Weaver SC, Rossi SL, Vasconcelos PFC, et al. A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage. Nature Communications. 8: 676. PMID 28939807 DOI: 10.1038/S41467-017-00737-8  0.371
2017 Kaiser JA, Wang T, Barrett AD. Virulence determinants of West Nile virus: how can these be used for vaccine design? Future Virology. 12: 283-295. PMID 28919920 DOI: 10.2217/fvl-2016-0141  0.334
2017 Richner JM, Jagger BW, Shan C, Fontes CR, Dowd KA, Cao B, Himansu S, Caine EA, Nunes BTD, Medeiros DBA, Muruato AE, Foreman BM, Luo H, Wang T, Barrett AD, et al. Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease. Cell. 170: 273-283.e12. PMID 28708997 DOI: 10.1016/J.Cell.2017.06.040  0.306
2017 Shan C, Muruato AE, Nunes BT, Luo H, Xie X, Medeiros DB, Wakamiya M, Tesh RB, Barrett AD, Wang T, Weaver SC, Vasconcelos PF, Rossi SL, Shi PY. A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models. Nature Medicine. PMID 28394328 DOI: 10.1038/Nm.4322  0.366
2017 Barrett AD. Yellow fever live attenuated vaccine: A very successful live attenuated vaccine but still we have problems controlling the disease. Vaccine. PMID 28366605 DOI: 10.1016/J.Vaccine.2017.03.032  0.348
2017 Collins ND, Barrett AD. Live Attenuated Yellow Fever 17D Vaccine: A Legacy Vaccine Still Controlling Outbreaks In Modern Day. Current Infectious Disease Reports. 19: 14. PMID 28275932 DOI: 10.1007/S11908-017-0566-9  0.319
2016 Vannice KS, Giersing BK, Kaslow DC, Griffiths E, Meyer H, Barrett A, Durbin AP, Wood D, Hombach J. Meeting Report: WHO consultation on considerations for regulatory expectations of Zika virus vaccines for use during an emergency. Vaccine. PMID 27916410 DOI: 10.1016/J.Vaccine.2016.10.034  0.394
2016 Xia H, Beck AS, Gargili A, Forrester N, Barrett AD, Bente DA. Transstadial Transmission and Long-term Association of Crimean-Congo Hemorrhagic Fever Virus in Ticks Shapes Genome Plasticity. Scientific Reports. 6: 35819. PMID 27775001 DOI: 10.1038/Srep35819  0.423
2016 Huang YS, Hettenbach SM, Park SL, Higgs S, Barrett AD, Hsu WW, Harbin JN, Cohnstaedt LW, Vanlandingham DL. Differential Infectivities among Different Japanese Encephalitis Virus Genotypes in Culex quinquefasciatus Mosquitoes. Plos Neglected Tropical Diseases. 10: e0005038. PMID 27706157 DOI: 10.1371/Journal.Pntd.0005038  0.442
2016 Thomas SJ, L'Azou M, Barrett AD, Jackson NA. Fast-Track Zika Vaccine Development - Is It Possible? The New England Journal of Medicine. 375: 1212-6. PMID 27682032 DOI: 10.1056/Nejmp1609300  0.306
2016 Shan C, Xie X, Barrett AD, Garcia-Blanco MA, Tesh RB, Vasconcelos PF, Vasilakis N, Weaver SC, Shi PY. Zika Virus: Diagnosis, Therapeutics, and Vaccine. Acs Infectious Diseases. 2: 170-172. PMID 27623030 DOI: 10.1021/Acsinfecdis.6B00030  0.46
2016 Metcalf CJ, Barrett A. Invasion Dynamics of Teratogenic Infections in Light of Rubella Control: Implications for Zika Virus. Plos Currents. 8. PMID 27617170 DOI: 10.1371/Currents.Outbreaks.873427B89Ab9C75Eb90C8Ddb8D8C7C90  0.441
2016 Barrett AD. Yellow Fever in Angola and Beyond - The Problem of Vaccine Supply and Demand. The New England Journal of Medicine. PMID 27276108 DOI: 10.1056/Nejmp1606997  0.389
2016 Shan C, Xie X, Muruato AE, Rossi SL, Roundy CM, Azar SR, Yang Y, Tesh RB, Bourne N, Barrett AD, Vasilakis N, Weaver SC, Shi PY. An Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral Inhibitors. Cell Host & Microbe. PMID 27198478 DOI: 10.1016/J.Chom.2016.05.004  0.412
2016 Calvert AE, Dixon KL, Piper J, Bennett SL, Thibodeaux BA, Barrett AD, Roehrig JT, Blair CD. A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from disease. Antiviral Research. PMID 27126613 DOI: 10.1016/J.Antiviral.2016.04.013  0.441
2015 Huang YJ, Harbin JN, Hettenbach SM, Maki E, Cohnstaedt LW, Barrett AD, Higgs S, Vanlandingham DL. Susceptibility of a North American Culex quinquefasciatus to Japanese Encephalitis Virus. Vector Borne and Zoonotic Diseases (Larchmont, N.Y.). 15: 709-11. PMID 26565775 DOI: 10.1089/Vbz.2015.1821  0.438
2015 Sarathy VV, Milligan GN, Bourne N, Barrett AD. Mouse models of dengue virus infection for vaccine testing. Vaccine. PMID 26478201 DOI: 10.1016/J.Vaccine.2015.09.112  0.428
2015 Beck AS, Barrett AD. Current status and future prospects of yellow fever vaccines. Expert Review of Vaccines. 14: 1479-92. PMID 26366673 DOI: 10.1586/14760584.2015.1083430  0.334
2015 Sarathy VV, Infante E, Li L, Campbell GA, Wang T, Paessler S, Beatty PR, Harris E, Milligan GN, Bourne N, Barrett AD. Characterization of lethal DENV-4 TVP-376 infection in mice lacking both alpha/beta and gamma interferon receptors (AG129) and comparison with the DENV-2 AG129 mouse model. The Journal of General Virology. PMID 26296350 DOI: 10.1099/Jgv.0.000246  0.398
2015 Milligan GN, Sarathy VV, Infante E, Li L, Campbell GA, Beatty PR, Harris E, Barrett AD, Bourne N. A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice. Plos One. 10: e0125476. PMID 25938762 DOI: 10.1371/Journal.Pone.0125476  0.426
2015 Xie G, Luo H, Tian B, Mann B, Bao X, McBride J, Tesh R, Barrett AD, Wang T. A West Nile virus NS4B-P38G mutant strain induces cell intrinsic innate cytokine responses in human monocytic and macrophage cells. Vaccine. 33: 869-78. PMID 25562791 DOI: 10.1016/J.Vaccine.2014.12.056  0.329
2015 Whiteman MC, Popov V, Sherman MB, Wen J, Barrett AD. Attenuated West Nile virus mutant NS1130-132QQA/175A/207A exhibits virus-induced ultrastructural changes and accumulation of protein in the endoplasmic reticulum. Journal of Virology. 89: 1474-8. PMID 25392222 DOI: 10.1128/Jvi.02215-14  0.461
2015 Sarathy VV, White M, Li L, Gorder SR, Pyles RB, Campbell GA, Milligan GN, Bourne N, Barrett AD. A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease. Journal of Virology. 89: 1254-66. PMID 25392217 DOI: 10.1128/Jvi.01320-14  0.412
2015 Pitcher TJ, Sarathy VV, Matsui K, Gromowski GD, Huang CY, Barrett AD. Functional analysis of dengue virus (DENV) type 2 envelope protein domain 3 type-specific and DENV complex-reactive critical epitope residues. The Journal of General Virology. 96: 288-93. PMID 25351518 DOI: 10.1099/Vir.0.070813-0  0.496
2014 Xie G, Whiteman MC, Wicker JA, Barrett AD, Wang T. In vitro analysis of MyD88-mediated cellular immune response to West Nile virus mutant strain infection. Journal of Visualized Experiments : Jove. e52121. PMID 25489855 DOI: 10.3791/52121  0.77
2014 Duggal NK, Bosco-Lauth A, Bowen RA, Wheeler SS, Reisen WK, Felix TA, Mann BR, Romo H, Swetnam DM, Barrett AD, Brault AC. Evidence for co-evolution of West Nile Virus and house sparrows in North America. Plos Neglected Tropical Diseases. 8: e3262. PMID 25357248 DOI: 10.1371/Journal.Pntd.0003262  0.461
2014 Fuchs J, Chu H, O'Day P, Pyles R, Bourne N, Das SC, Milligan GN, Barrett AD, Partidos CD, Osorio JE. Investigating the efficacy of monovalent and tetravalent dengue vaccine formulations against DENV-4 challenge in AG129 mice. Vaccine. 32: 6537-43. PMID 25239488 DOI: 10.1016/J.Vaccine.2014.08.087  0.395
2014 Zhang J, Wang J, Pang L, Xie G, Welte T, Saxena V, Wicker J, Mann B, Soong L, Barrett A, Born W, O'Brien R, Wang T. The co-stimulatory effects of MyD88-dependent Toll-like receptor signaling on activation of murine γδ T cells. Plos One. 9: e108156. PMID 25232836 DOI: 10.1371/Journal.Pone.0108156  0.746
2014 Maillard RA, Liu T, Beasley DW, Barrett AD, Hilser VJ, Lee JC. Thermodynamic mechanism for the evasion of antibody neutralization in flaviviruses. Journal of the American Chemical Society. 136: 10315-24. PMID 24950171 DOI: 10.1021/Ja503318X  0.38
2014 Barrett AD. Economic burden of West Nile virus in the United States. The American Journal of Tropical Medicine and Hygiene. 90: 389-90. PMID 24515938 DOI: 10.4269/Ajtmh.14-0009  0.332
2014 Schuh AJ, Ward MJ, Leigh Brown AJ, Barrett AD. Dynamics of the emergence and establishment of a newly dominant genotype of Japanese encephalitis virus throughout Asia. Journal of Virology. 88: 4522-32. PMID 24501419 DOI: 10.1128/Jvi.02686-13  0.491
2014 Beck A, Tesh RB, Wood TG, Widen SG, Ryman KD, Barrett AD. Comparison of the live attenuated yellow fever vaccine 17D-204 strain to its virulent parental strain Asibi by deep sequencing. The Journal of Infectious Diseases. 209: 334-44. PMID 24141982 DOI: 10.1093/Infdis/Jit546  0.412
2013 Mann BR, McMullen AR, Swetnam DM, Barrett AD. Molecular epidemiology and evolution of West Nile virus in North America. International Journal of Environmental Research and Public Health. 10: 5111-29. PMID 24135819 DOI: 10.3390/Ijerph10105111  0.381
2013 Schuh AJ, Ward MJ, Brown AJ, Barrett AD. Phylogeography of Japanese encephalitis virus: genotype is associated with climate. Plos Neglected Tropical Diseases. 7: e2411. PMID 24009790 DOI: 10.1371/Journal.Pntd.0002411  0.462
2013 Mann BR, McMullen AR, Swetnam DM, Salvato V, Reyna M, Guzman H, Bueno R, Dennett JA, Tesh RB, Barrett AD. Continued evolution of West Nile virus, Houston, Texas, USA, 2002-2012. Emerging Infectious Diseases. 19: 1418-27. PMID 23965756 DOI: 10.3201/Eid1909.130377  0.425
2013 Xie G, Welte T, Wang J, Whiteman MC, Wicker JA, Saxena V, Cong Y, Barrett AD, Wang T. A West Nile virus NS4B-P38G mutant strain induces adaptive immunity via TLR7-MyD88-dependent and independent signaling pathways. Vaccine. 31: 4143-51. PMID 23845800 DOI: 10.1016/J.Vaccine.2013.06.093  0.782
2013 Beasley DW, Barrett AD, Tesh RB. Resurgence of West Nile neurologic disease in the United States in 2012: what happened? What needs to be done? Antiviral Research. 99: 1-5. PMID 23624155 DOI: 10.1016/J.Antiviral.2013.04.015  0.424
2013 Schuh AJ, Guzman H, Tesh RB, Barrett AD. Genetic diversity of Japanese encephalitis virus isolates obtained from the Indonesian archipelago between 1974 and 1987. Vector Borne and Zoonotic Diseases (Larchmont, N.Y.). 13: 479-88. PMID 23590316 DOI: 10.1089/Vbz.2011.0870  0.427
2013 Beck A, Guzman H, Li L, Ellis B, Tesh RB, Barrett AD. Phylogeographic reconstruction of African yellow fever virus isolates indicates recent simultaneous dispersal into east and west Africa. Plos Neglected Tropical Diseases. 7: e1910. PMID 23516640 DOI: 10.1371/Journal.Pntd.0001910  0.401
2013 Van Slyke GA, Jia Y, Whiteman MC, Wicker JA, Barrett AD, Kramer LD. Vertebrate attenuated West Nile virus mutants have differing effects on vector competence in Culex tarsalis mosquitoes. The Journal of General Virology. 94: 1069-72. PMID 23303828 DOI: 10.1099/Vir.0.049833-0  0.817
2013 Edupuganti S, Eidex RB, Keyserling H, Akondy RS, Lanciotti R, Orenstein W, del Rio C, Pan Y, Querec T, Lipman H, Barrett A, Ahmed R, Teuwen D, Cetron M, Mulligan MJ, et al. A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immunogenicity. The American Journal of Tropical Medicine and Hygiene. 88: 172-7. PMID 23208880 DOI: 10.4269/Ajtmh.2012.12-0179  0.395
2013 Mann BR, McMullen AR, Guzman H, Tesh RB, Barrett AD. Dynamic transmission of West Nile virus across the United States-Mexican border. Virology. 436: 75-80. PMID 23141421 DOI: 10.1016/J.Virol.2012.10.023  0.419
2013 McMullen AR, Albayrak H, May FJ, Davis CT, Beasley DW, Barrett AD. Molecular evolution of lineage 2 West Nile virus. The Journal of General Virology. 94: 318-25. PMID 23136360 DOI: 10.1099/Vir.0.046888-0  0.419
2013 Brinley AA, Theriot CA, Nelman-Gonzalez M, Crucian B, Stowe RP, Barrett AD, Pierson DL. Characterization of Epstein-Barr virus reactivation in a modeled spaceflight system. Journal of Cellular Biochemistry. 114: 616-24. PMID 22991253 DOI: 10.1002/Jcb.24403  0.328
2012 Kollaritsch H, Paulke-Korinek M, Holzmann H, Hombach J, Bjorvatn B, Barrett A. Vaccines and vaccination against tick-borne encephalitis Expert Review of Vaccines. 11: 1103-1119. PMID 23151167 DOI: 10.1586/Erv.12.86  0.321
2012 Wicker JA, Whiteman MC, Beasley DW, Davis CT, McGee CE, Lee JC, Higgs S, Kinney RM, Huang CY, Barrett AD. Mutational analysis of the West Nile virus NS4B protein. Virology. 426: 22-33. PMID 22314017 DOI: 10.1016/J.Virol.2011.11.022  0.804
2012 Pitcher TJ, Gromowski GD, Beasley DW, Barrett AD. Conservation of the DENV-2 type-specific and DEN complex-reactive antigenic sites among DENV-2 genotypes. Virology. 422: 386-92. PMID 22153298 DOI: 10.1016/J.Virol.2011.10.020  0.373
2011 Brault AC, Langevin SA, Ramey WN, Fang Y, Beasley DW, Barker CM, Sanders TA, Reisen WK, Barrett AD, Bowen RA. Reduced avian virulence and viremia of West Nile virus isolates from Mexico and Texas. The American Journal of Tropical Medicine and Hygiene. 85: 758-67. PMID 21976584 DOI: 10.4269/Ajtmh.2011.10-0439  0.478
2011 Aguilar PV, Barrett AD, Saeed MF, Watts DM, Russell K, Guevara C, Ampuero JS, Suarez L, Cespedes M, Montgomery JM, Halsey ES, Kochel TJ. Iquitos virus: a novel reassortant Orthobunyavirus associated with human illness in Peru. Plos Neglected Tropical Diseases. 5: e1315. PMID 21949892 DOI: 10.1371/Journal.Pntd.0001315  0.694
2011 Whiteman MC, Wicker JA, Kinney RM, Huang CY, Solomon T, Barrett AD. Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness. Vaccine. 29: 9702-10. PMID 21945257 DOI: 10.1016/J.Vaccine.2011.09.036  0.818
2011 Mansfield KL, Horton DL, Johnson N, Li L, Barrett AD, Smith DJ, Galbraith SE, Solomon T, Fooks AR. Flavivirus-induced antibody cross-reactivity. The Journal of General Virology. 92: 2821-9. PMID 21900425 DOI: 10.1099/Vir.0.031641-0  0.471
2011 Langevin SA, Bowen RA, Ramey WN, Sanders TA, Maharaj PD, Fang Y, Cornelius J, Barker CM, Reisen WK, Beasley DW, Barrett AD, Kinney RM, Huang CY, Brault AC. Envelope and pre-membrane protein structural amino acid mutations mediate diminished avian growth and virulence of a Mexican West Nile virus isolate. The Journal of General Virology. 92: 2810-20. PMID 21865445 DOI: 10.1099/Vir.0.035535-0  0.511
2011 Schmitz J, Roehrig J, Barrett A, Hombach J. Next generation dengue vaccines: a review of candidates in preclinical development. Vaccine. 29: 7276-84. PMID 21781998 DOI: 10.1016/J.Vaccine.2011.07.017  0.317
2011 Coller BA, Barrett AD, Thomas SJ. The development of Dengue vaccines. Introduction. Vaccine. 29: 7219-20. PMID 21708208 DOI: 10.1016/J.Vaccine.2011.06.057  0.311
2011 Welte T, Xie G, Wicker JA, Whiteman MC, Li L, Rachamallu A, Barrett A, Wang T. Immune responses to an attenuated West Nile virus NS4B-P38G mutant strain. Vaccine. 29: 4853-61. PMID 21549792 DOI: 10.1016/J.Vaccine.2011.04.057  0.801
2011 McMullen AR, May FJ, Li L, Guzman H, Bueno R, Dennett JA, Tesh RB, Barrett AD. Evolution of new genotype of West Nile virus in North America. Emerging Infectious Diseases. 17: 785-93. PMID 21529385 DOI: 10.3201/Eid1705.101707  0.438
2011 May FJ, Davis CT, Tesh RB, Barrett AD. Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas. Journal of Virology. 85: 2964-74. PMID 21159871 DOI: 10.1128/Jvi.01963-10  0.46
2011 Schuh AJ, Tesh RB, Barrett AD. Genetic characterization of Japanese encephalitis virus genotype II strains isolated from 1951 to 1978. The Journal of General Virology. 92: 516-27. PMID 21123550 DOI: 10.1099/Vir.0.027110-0  0.463
2010 Ferguson M, Shin Jinho J, Knezevic I, Minor P, Barrett A. WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13-14 May 2009 Vaccine. 28: 8236-8245. PMID 21055492 DOI: 10.1016/J.Vaccine.2010.10.070  0.334
2010 Gromowski GD, Roehrig JT, Diamond MS, Lee JC, Pitcher TJ, Barrett AD. Mutations of an antibody binding energy hot spot on domain III of the dengue 2 envelope glycoprotein exploited for neutralization escape. Virology. 407: 237-46. PMID 20832836 DOI: 10.1016/J.Virol.2010.06.044  0.316
2010 Bowick GC, Barrett AD. Comparative pathogenesis and systems biology for biodefense virus vaccine development. Journal of Biomedicine & Biotechnology. 2010: 236528. PMID 20617142 DOI: 10.1155/2010/236528  0.432
2010 May FJ, Li L, Davis CT, Galbraith SE, Barrett AD. Multiple pathways to the attenuation of West Nile virus in south-east Texas in 2003. Virology. 405: 8-14. PMID 20580395 DOI: 10.1016/J.Virol.2010.04.022  0.471
2010 Matsui K, Gromowski GD, Li L, Barrett AD. Characterization of a dengue type-specific epitope on dengue 3 virus envelope protein domain III. The Journal of General Virology. 91: 2249-53. PMID 20444995 DOI: 10.1099/Vir.0.021220-0  0.397
2010 Laurent-Rolle M, Boer EF, Lubick KJ, Wolfinbarger JB, Carmody AB, Rockx B, Liu W, Ashour J, Shupert WL, Holbrook MR, Barrett AD, Mason PW, Bloom ME, García-Sastre A, Khromykh AA, et al. The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling. Journal of Virology. 84: 3503-15. PMID 20106931 DOI: 10.1128/Jvi.01161-09  0.645
2010 Whiteman MC, Li L, Wicker JA, Kinney RM, Huang C, Beasley DW, Chung KM, Diamond MS, Solomon T, Barrett AD. Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus. Vaccine. 28: 1075-83. PMID 19896447 DOI: 10.1016/J.Vaccine.2009.10.112  0.805
2010 Schuh AJ, Li L, Tesh RB, Innis BL, Barrett AD. Genetic characterization of early isolates of Japanese encephalitis virus: genotype II has been circulating since at least 1951. The Journal of General Virology. 91: 95-102. PMID 19776238 DOI: 10.1099/Vir.0.013631-0  0.451
2009 Barrett AD, Beasley DW. Development pathway for biodefense vaccines. Vaccine. 27: D2-7. PMID 19837280 DOI: 10.1016/J.Vaccine.2009.07.094  0.312
2009 Barrett AD, Teuwen DE. Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place? Current Opinion in Immunology. 21: 308-13. PMID 19520559 DOI: 10.1016/J.Coi.2009.05.018  0.321
2009 Poland G, Barrett A. The old and the new: successful vaccines of the 20th century and approaches to making vaccines for the important diseases of the 21st century. Current Opinion in Immunology. 21: 305-307. PMID 19500965 DOI: 10.1016/J.Coi.2009.05.014  0.315
2009 Matsui K, Gromowski GD, Li L, Schuh AJ, Lee JC, Barrett AD. Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III. Virology. 384: 16-20. PMID 19101005 DOI: 10.1016/J.Virol.2008.11.013  0.414
2009 Thomas SJ, Hombach J, Barrett A. Scientific consultation on cell mediated immunity (CMI) in dengue and dengue vaccine development Vaccine. 27: 355-368. PMID 19022321 DOI: 10.1016/J.Vaccine.2008.10.086  0.397
2008 Volk DE, Anderson KM, Gandham SH, May FJ, Li L, Beasley DW, Barrett AD, Gorenstein DG. NMR assignments of the sylvatic dengue 1 virus envelope protein domain III. Biomolecular Nmr Assignments. 2: 155-7. PMID 19636893 DOI: 10.1007/S12104-008-9109-5  0.433
2008 Ellis BR, Barrett AD. The enigma of yellow fever in East Africa. Reviews in Medical Virology. 18: 331-46. PMID 18615782 DOI: 10.1002/Rmv.584  0.375
2008 Gromowski GD, Barrett ND, Barrett AD. Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus. Journal of Virology. 82: 8828-37. PMID 18562544 DOI: 10.1128/Jvi.00606-08  0.46
2008 Roehrig JT, Hombach J, Barrett AD. Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses. Viral Immunology. 21: 123-32. PMID 18476771 DOI: 10.1089/Vim.2008.0007  0.372
2008 Barrett AD. Flavivirus DNA vaccine with a kick. Nature Biotechnology. 26: 525-6. PMID 18464782 DOI: 10.1038/Nbt0508-525  0.358
2008 Maillard RA, Jordan M, Beasley DW, Barrett AD, Lee JC. Long range communication in the envelope protein domain III and its effect on the resistance of West Nile virus to antibody-mediated neutralization. The Journal of Biological Chemistry. 283: 613-22. PMID 17986445 DOI: 10.1074/Jbc.M706031200  0.38
2008 Ferguson M, Johnes S, Li L, Heath A, Barrett A. Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines – Report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies Biologicals. 36: 111-116. PMID 17892945 DOI: 10.1016/J.Biologicals.2007.07.002  0.505
2008 Volk D, Anderson K, Gandham S, May F, Beasley D, Barrett A, Gorenstein D. 1H, 13C and 15N chemical shifts of the sylvatic Dengue 1 Envelope Protein Domain III, strain P72-1244 Journal of Back and Musculoskeletal Rehabilitation. DOI: 10.13018/Bmr15782  0.314
2007 Sukupolvi-Petty S, Austin SK, Purtha WE, Oliphant T, Nybakken GE, Schlesinger JJ, Roehrig JT, Gromowski GD, Barrett AD, Fremont DH, Diamond MS. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. Journal of Virology. 81: 12816-26. PMID 17881453 DOI: 10.1128/Jvi.00432-07  0.328
2007 Gromowski GD, Barrett AD. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Virology. 366: 349-60. PMID 17719070 DOI: 10.1016/J.Virol.2007.05.042  0.494
2007 Schepp-Berglind J, Luo M, Wang D, Wicker JA, Raja NU, Hoel BD, Holman DH, Barrett AD, Dong JY. Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses. Clinical and Vaccine Immunology : Cvi. 14: 1117-26. PMID 17634508 DOI: 10.1128/Cvi.00070-07  0.807
2007 Davis CT, Li L, May FJ, Bueno R, Dennett JA, Bala AA, Guzman H, Quiroga-Elizondo D, Tesh RB, Barrett AD. Genetic stasis of dominant West Nile virus genotype, Houston, Texas. Emerging Infectious Diseases. 13: 601-4. PMID 17553276 DOI: 10.3201/eid1304.061473  0.341
2007 Bryant JE, Holmes EC, Barrett AD. Out of Africa: a molecular perspective on the introduction of yellow fever virus into the Americas. Plos Pathogens. 3: e75. PMID 17511518 DOI: 10.1371/Journal.Ppat.0030075  0.662
2007 Hombach J, Cardosa MJ, Sabchareon A, Vaughn DW, Barrett AD. Scientific consultation on immunological correlates of protection induced by dengue vaccines report from a meeting held at the World Health Organization 17-18 November 2005. Vaccine. 25: 4130-9. PMID 17428588 DOI: 10.1016/J.Vaccine.2007.02.079  0.314
2007 Davis CT, Galbraith SE, Zhang S, Whiteman MC, Li L, Kinney RM, Barrett AD. A combination of naturally occurring mutations in North American West Nile virus nonstructural protein genes and in the 3' untranslated region alters virus phenotype. Journal of Virology. 81: 6111-6. PMID 17376926 DOI: 10.1128/Jvi.02387-06  0.389
2007 Barrett AD, Monath TP, Barban V, Niedrig M, Teuwen DE. 17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005. Vaccine. 25: 2758-65. PMID 17368349 DOI: 10.1016/J.Vaccine.2006.12.015  0.35
2007 Barrett AD, Higgs S. Yellow fever: a disease that has yet to be conquered. Annual Review of Entomology. 52: 209-29. PMID 16913829 DOI: 10.1146/Annurev.Ento.52.110405.091454  0.456
2006 Wang T, Gao Y, Scully E, Davis CT, Anderson JF, Welte T, Ledizet M, Koski R, Madri JA, Barrett A, Yin Z, Craft J, Fikrig E. Gamma delta T cells facilitate adaptive immunity against West Nile virus infection in mice. Journal of Immunology (Baltimore, Md. : 1950). 177: 1825-32. PMID 16849493 DOI: 10.4049/Jimmunol.177.3.1825  0.447
2006 German AC, Myint KS, Mai NT, Pomeroy I, Phu NH, Tzartos J, Winter P, Collett J, Farrar J, Barrett A, Kipar A, Esiri MM, Solomon T. A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model. Transactions of the Royal Society of Tropical Medicine and Hygiene. 100: 1135-45. PMID 16814333 DOI: 10.1016/J.Trstmh.2006.02.008  0.402
2006 Zhang S, Li L, Woodson SE, Huang CY, Kinney RM, Barrett AD, Beasley DW. A mutation in the envelope protein fusion loop attenuates mouse neuroinvasiveness of the NY99 strain of West Nile virus. Virology. 353: 35-40. PMID 16806383 DOI: 10.1016/J.Virol.2006.05.025  0.801
2006 Volk DE, Chavez L, Beasley DW, Barrett AD, Holbrook MR, Gorenstein DG. Structure of the envelope protein domain III of Omsk hemorrhagic fever virus. Virology. 351: 188-95. PMID 16647096 DOI: 10.1016/J.Virol.2006.03.030  0.694
2006 Wicker JA, Whiteman MC, Beasley DW, Davis CT, Zhang S, Schneider BS, Higgs S, Kinney RM, Barrett AD. A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice. Virology. 349: 245-53. PMID 16624366 DOI: 10.1016/J.Virol.2006.03.007  0.807
2006 von Lindern JJ, Aroner S, Barrett ND, Wicker JA, Davis CT, Barrett AD. Genome analysis and phylogenetic relationships between east, central and west African isolates of Yellow fever virus. The Journal of General Virology. 87: 895-907. PMID 16528039 DOI: 10.1099/Vir.0.81236-0  0.792
2006 Deardorff E, Estrada-Franco J, Brault AC, Navarro-Lopez R, Campomanes-Cortes A, Paz-Ramirez P, Solis-Hernandez M, Ramey WN, Davis CT, Beasley DW, Tesh RB, Barrett AD, Weaver SC. Introductions of West Nile virus strains to Mexico. Emerging Infectious Diseases. 12: 314-8. PMID 16494762 DOI: 10.3201/Eid1202.050871  0.461
2006 Engel AR, Vasconcelos PF, McArthur MA, Barrett AD. Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil. Vaccine. 24: 2803-9. PMID 16464518 DOI: 10.1016/J.Vaccine.2006.01.009  0.778
2005 Davis CT, Ebel GD, Lanciotti RS, Brault AC, Guzman H, Siirin M, Lambert A, Parsons RE, Beasley DW, Novak RJ, Elizondo-Quiroga D, Green EN, Young DS, Stark LM, Drebot MA, ... ... Barrett AD, et al. Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype. Virology. 342: 252-65. PMID 16137736 DOI: 10.1016/J.Virol.2005.07.022  0.452
2005 Beasley DW, Whiteman MC, Zhang S, Huang CY, Schneider BS, Smith DR, Gromowski GD, Higgs S, Kinney RM, Barrett AD. Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains. Journal of Virology. 79: 8339-47. PMID 15956579 DOI: 10.1128/Jvi.79.13.8339-8347.2005  0.49
2005 McArthur MA, Xiao SY, Barrett AD. Phenotypic and molecular characterization of a non-lethal, hamster-viscerotropic strain of yellow fever virus. Virus Research. 110: 65-71. PMID 15845256 DOI: 10.1016/J.Virusres.2005.01.004  0.749
2005 Hombach J, Barrett A, Cardosa MJ, Deubel V, Guzman M, Kurane I, Roehrig JT, Sabchareon A, Kieny MP. Review on flavivirus vaccine development: Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand Vaccine. 23: 2689-2695. PMID 15841565 DOI: 10.1016/J.Vaccine.2004.11.040  0.303
2005 Li L, Barrett AD, Beasley DW. Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains. Virology. 335: 99-105. PMID 15823609 DOI: 10.1016/J.Virol.2005.02.011  0.463
2005 Monath TP, Kanesa-Thasan N, Guirakhoo F, Pugachev K, Almond J, Lang J, Quentin-Millet MJ, Barrett AD, Brinton MA, Cetron MS, Barwick RS, Chambers TJ, Halstead SB, Roehrig JT, Kinney RM, et al. Recombination and flavivirus vaccines: a commentary. Vaccine. 23: 2956-8. PMID 15811640 DOI: 10.1016/J.Vaccine.2004.11.069  0.37
2005 Bryant JE, Vasconcelos PF, Rijnbrand RC, Mutebi JP, Higgs S, Barrett AD. Size heterogeneity in the 3' noncoding region of South American isolates of yellow fever virus. Journal of Virology. 79: 3807-21. PMID 15731274 DOI: 10.1128/Jvi.79.6.3807-3821.2005  0.67
2005 Halstead SB, Heinz FX, Barrett AD, Roehrig JT. Dengue virus: molecular basis of cell entry and pathogenesis, 25-27 June 2003, Vienna, Austria. Vaccine. 23: 849-56. PMID 15603884 DOI: 10.1016/J.Vaccine.2004.03.069  0.456
2005 Holbrook MR, Aronson JF, Campbell GA, Jones S, Feldmann H, Barrett AD. An animal model for the tickborne flavivirus--Omsk hemorrhagic fever virus. The Journal of Infectious Diseases. 191: 100-8. PMID 15593010 DOI: 10.1086/426397  0.661
2004 Beasley DW, Davis CT, Estrada-Franco J, Navarro-Lopez R, Campomanes-Cortes A, Tesh RB, Weaver SC, Barrett AD. Genome sequence and attenuating mutations in West Nile virus isolate from Mexico. Emerging Infectious Diseases. 10: 2221-4. PMID 15663867 DOI: 10.3201/Eid1012.040647  0.449
2004 Granwehr BP, Li L, Davis CT, Beasley DW, Barrett AD. Characterization of a West Nile virus isolate from a human on the Gulf Coast of Texas. Journal of Clinical Microbiology. 42: 5375-7. PMID 15528747 DOI: 10.1128/Jcm.42.11.5375-5377.2004  0.434
2004 Davis CT, Beasley DW, Guzman H, Siirin M, Parsons RE, Tesh RB, Barrett AD. Emergence of attenuated West Nile virus variants in Texas, 2003. Virology. 330: 342-50. PMID 15527859 DOI: 10.1016/J.Virol.2004.09.016  0.437
2004 Mutebi JP, Gianella A, Travassos da Rosa A, Tesh RB, Barrett AD, Higgs S. Yellow fever virus infectivity for Bolivian Aedes aegypti mosquitoes. Emerging Infectious Diseases. 10: 1657-60. PMID 15498171 DOI: 10.3201/Eid1009.031124  0.459
2004 Vasconcelos PF, Bryant JE, da Rosa TP, Tesh RB, Rodrigues SG, Barrett AD. Genetic divergence and dispersal of yellow fever virus, Brazil. Emerging Infectious Diseases. 10: 1578-84. PMID 15498159 DOI: 10.3201/Eid1009.040197  0.715
2004 Weaver SC, Barrett AD. Transmission cycles, host range, evolution and emergence of arboviral disease. Nature Reviews. Microbiology. 2: 789-801. PMID 15378043 DOI: 10.1038/Nrmicro1006  0.39
2004 Holbrook MR, Shope RE, Barrett AD. Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses. Journal of Clinical Microbiology. 42: 4101-10. PMID 15364996 DOI: 10.1128/Jcm.42.9.4101-4110.2004  0.646
2004 Granwehr BP, Lillibridge KM, Higgs S, Mason PW, Aronson JF, Campbell GA, Barrett AD. West Nile virus: where are we now? The Lancet. Infectious Diseases. 4: 547-56. PMID 15336221 DOI: 10.1016/S1473-3099(04)01128-4  0.467
2004 Mutebi JP, Rijnbrand RC, Wang H, Ryman KD, Wang E, Fulop LD, Titball R, Barrett AD. Genetic relationships and evolution of genotypes of yellow fever virus and other members of the yellow fever virus group within the Flavivirus genus based on the 3' noncoding region. Journal of Virology. 78: 9652-65. PMID 15331698 DOI: 10.1128/Jvi.78.18.9652-9665.2004  0.471
2004 Beasley DW, Li L, Suderman MT, Guirakhoo F, Trent DW, Monath TP, Shope RE, Barrett AD. Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine. Vaccine. 22: 3722-6. PMID 15315852 DOI: 10.1016/J.Vaccine.2004.03.027  0.45
2004 Gerrard SR, Li L, Barrett AD, Nichol ST. Ngari virus is a Bunyamwera virus reassortant that can be associated with large outbreaks of hemorrhagic fever in Africa. Journal of Virology. 78: 8922-6. PMID 15280501 DOI: 10.1128/JVI.78.16.8922-8926.2004  0.396
2004 Barrett AD. Current status of the Arilvax; yellow fever vaccine. Expert Review of Vaccines. 3: 413-20. PMID 15270646 DOI: 10.1586/14760584.3.4.413  0.342
2004 Yu S, Wuu A, Basu R, Holbrook MR, Barrett AD, Lee JC. Solution structure and structural dynamics of envelope protein domain III of mosquito- and tick-borne flaviviruses. Biochemistry. 43: 9168-76. PMID 15248774 DOI: 10.1021/Bi049324G  0.644
2004 Volk DE, Kallick DA, Holbrook MR, Beasley DW, Barrett AD, Gorenstein DG. 1H, 13C and 15N resonance assignments for domain III of the West Nile virus envelope protein. Journal of Biomolecular Nmr. 29: 445-6. PMID 15213461 DOI: 10.1023/B:Jnmr.0000032551.56061.68  0.619
2004 Volk DE, Beasley DW, Kallick DA, Holbrook MR, Barrett AD, Gorenstein DG. Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus. The Journal of Biological Chemistry. 279: 38755-61. PMID 15190071 DOI: 10.1074/Jbc.M402385200  0.582
2004 Beasley DW, Holbrook MR, Travassos Da Rosa AP, Coffey L, Carrara AS, Phillippi-Falkenstein K, Bohm RP, Ratterree MS, Lillibridge KM, Ludwig GV, Estrada-Franco J, Weaver SC, Tesh RB, Shope RE, Barrett AD. Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection. Journal of Clinical Microbiology. 42: 2759-65. PMID 15184463 DOI: 10.1128/Jcm.42.6.2759-2765.2004  0.675
2004 Li L, Rollin PE, Nichol ST, Shope RE, Barrett AD, Holbrook MR. Molecular determinants of antigenicity of two subtypes of the tick-borne flavivirus Omsk haemorrhagic fever virus. The Journal of General Virology. 85: 1619-24. PMID 15166446 DOI: 10.1099/Vir.0.19766-0  0.7
2004 Beasley DW, Davis CT, Whiteman M, Granwehr B, Kinney RM, Barrett AD. Molecular determinants of virulence of West Nile virus in North America. Archives of Virology. Supplementum. 35-41. PMID 15119761  0.368
2004 Ratterree MS, Gutierrez RA, Travassos da Rosa AP, Dille BJ, Beasley DW, Bohm RP, Desai SM, Didier PJ, Bikenmeyer LG, Dawson GJ, Leary TP, Schochetman G, Phillippi-Falkenstein K, Arroyo J, Barrett AD, et al. Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection. The Journal of Infectious Diseases. 189: 669-76. PMID 14767821 DOI: 10.1086/381461  0.392
2003 Estrada-Franco JG, Navarro-Lopez R, Beasley DW, Coffey L, Carrara AS, Travassos da Rosa A, Clements T, Wang E, Ludwig GV, Cortes AC, Ramírez PP, Tesh RB, Barrett AD, Weaver SC. West Nile virus in Mexico: evidence of widespread circulation since July 2002. Emerging Infectious Diseases. 9: 1604-7. PMID 14720402 DOI: 10.3201/Eid0912.030564  0.432
2003 Davis CT, Beasley DW, Guzman H, Raj R, D'Anton M, Novak RJ, Unnasch TR, Tesh RB, Barrett AD. Genetic variation among temporally and geographically distinct West Nile virus isolates, United States, 2001, 2002. Emerging Infectious Diseases. 9: 1423-9. PMID 14718086 DOI: 10.3201/Eid0911.030301  0.399
2003 Bryant JE, Barrett AD. Comparative phylogenies of yellow fever isolates from Peru and Brazil. Fems Immunology and Medical Microbiology. 39: 103-18. PMID 14625093 DOI: 10.1016/S0928-8244(03)00238-4  0.638
2003 Bryant J, Wang H, Cabezas C, Ramirez G, Watts D, Russell K, Barrett A. Enzootic transmission of yellow fever virus in Peru. Emerging Infectious Diseases. 9: 926-33. PMID 12967489 DOI: 10.3201/Eid0908.030075  0.692
2003 Lin D, Li L, Dick D, Shope RE, Feldmann H, Barrett AD, Holbrook MR. Analysis of the complete genome of the tick-borne flavivirus Omsk hemorrhagic fever virus. Virology. 313: 81-90. PMID 12951023 DOI: 10.1016/S0042-6822(03)00246-0  0.704
2003 White MA, Liu D, Holbrook MR, Shope RE, Barrett AD, Fox RO. Crystallization and preliminary X-ray diffraction analysis of Langat virus envelope protein domain III. Acta Crystallographica. Section D, Biological Crystallography. 59: 1049-51. PMID 12777770 DOI: 10.1107/S0907444903004475  0.558
2003 Solomon T, Fisher AF, Beasley DW, Mandava P, Granwehr BP, Langsjoen H, Travassos Da Rosa AP, Barrett AD, Tesh RB. Natural and nosocomial infection in a patient with West Nile encephalitis and extrapyramidal movement disorders. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 36: E140-5. PMID 12766856 DOI: 10.1086/374936  0.36
2003 Beasley DW, Davis CT, Guzman H, Vanlandingham DL, Travassos da Rosa AP, Parsons RE, Higgs S, Tesh RB, Barrett AD. Limited evolution of West Nile virus has occurred during its southwesterly spread in the United States. Virology. 309: 190-5. PMID 12758166 DOI: 10.1016/S0042-6822(03)00150-8  0.459
2003 Solomon T, Ni H, Beasley DW, Ekkelenkamp M, Cardosa MJ, Barrett AD. Origin and evolution of Japanese encephalitis virus in southeast Asia. Journal of Virology. 77: 3091-8. PMID 12584335 DOI: 10.1128/Jvi.77.5.3091-3098.2003  0.496
2003 McArthur MA, Suderman MT, Mutebi JP, Xiao SY, Barrett AD. Molecular characterization of a hamster viscerotropic strain of yellow fever virus. Journal of Virology. 77: 1462-8. PMID 12502861 DOI: 10.1128/Jvi.77.2.1462-1468.2003  0.752
2003 Mutebi JP, Barrett AD. The epidemiology of yellow fever in Africa. Microbes and Infection. 4: 1459-68. PMID 12475636 DOI: 10.1016/S1286-4579(02)00028-X  0.377
2002 Beasley DW, Barrett AD. Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. Journal of Virology. 76: 13097-100. PMID 12438639 DOI: 10.1128/Jvi.76.24.13097-13100.2002  0.473
2002 Holbrook MR, Barrett AD. Molecular epidemiology of Japanese encephalitis virus. Current Topics in Microbiology and Immunology. 267: 75-90. PMID 12083001 DOI: 10.1007/978-3-642-59403-8_4  0.698
2002 Mackenzie JS, Barrett AD, Deubel V. The Japanese encephalitis serological group of flaviviruses: a brief introduction to the group. Current Topics in Microbiology and Immunology. 267: 1-10. PMID 12082984 DOI: 10.1007/978-3-642-59403-8_1  0.493
2002 Beasley DW, Li L, Suderman MT, Barrett AD. Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology. 296: 17-23. PMID 12036314 DOI: 10.1006/Viro.2002.1372  0.533
2002 Crocquet-Valdes PA, Díaz-Montero CM, Feng HM, Li H, Barrett AD, Walker DH. Immunization with a portion of rickettsial outer membrane protein A stimulates protective immunity against spotted fever rickettsiosis. Vaccine. 20: 979-88. PMID 11738766 DOI: 10.1016/S0264-410X(01)00377-2  0.344
2001 Beasley DW, Li L, Suderman MT, Barrett AD. West Nile virus strains differ in mouse neurovirulence and binding to mouse or human brain membrane receptor preparations. Annals of the New York Academy of Sciences. 951: 332-5. PMID 11797791 DOI: 10.1111/J.1749-6632.2001.Tb02710.X  0.384
2001 Beasley DW, Suderman MT, Holbrook MR, Barrett AD. Nucleotide sequencing and serological evidence that the recently recognized deer tick virus is a genotype of Powassan virus. Virus Research. 79: 81-9. PMID 11551648 DOI: 10.1016/S0168-1702(01)00330-6  0.698
2001 Saeed MF, Wang H, Suderman M, Beasley DW, Travassos da Rosa A, Li L, Shope RE, Tesh RB, Barrett AD. Jatobal virus is a reassortant containing the small RNA of Oropouche virus. Virus Research. 77: 25-30. PMID 11451484 DOI: 10.1016/S0168-1702(01)00262-3  0.694
2001 Holbrook MR, Ni H, Shope RE, Barrett AD. Amino acid substitution(s) in the stem-anchor region of langat virus envelope protein attenuates mouse neurovirulence. Virology. 286: 54-61. PMID 11448158 DOI: 10.1006/Viro.2001.0959  0.681
2001 Mutebi JP, Wang H, Li L, Bryant JE, Barrett AD. Phylogenetic and evolutionary relationships among yellow fever virus isolates in Africa. Journal of Virology. 75: 6999-7008. PMID 11435580 DOI: 10.1128/Jvi.75.15.6999-7008.2001  0.681
2001 Bhardwaj S, Holbrook M, Shope RE, Barrett AD, Watowich SJ. Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein. Journal of Virology. 75: 4002-7. PMID 11264392 DOI: 10.1128/Jvi.75.8.4002-4007.2001  0.603
2001 Holbrook MR, Wang H, Barrett AD. Langat virus M protein is structurally homologous to prM. Journal of Virology. 75: 3999-4001. PMID 11264391 DOI: 10.1128/Jvi.75.8.3999-4001.2001  0.631
2001 Shurtleff AC, Beasley DW, Chen JJ, Ni H, Suderman MT, Wang H, Xu R, Wang E, Weaver SC, Watts DM, Russell KL, Barrett AD. Genetic variation in the 3' non-coding region of dengue viruses. Virology. 281: 75-87. PMID 11222098 DOI: 10.1006/Viro.2000.0748  0.465
2001 Wang H, Beasley DW, Li L, Holbrook MR, Barrett AD. Nucleotide sequence and deduced amino acid sequence of the medium RNA segment of Oropouche, a Simbu serogroup virus: comparison with the middle RNA of Bunyamwera and California serogroup viruses. Virus Research. 73: 153-62. PMID 11172919 DOI: 10.1016/S0168-1702(00)00234-3  0.621
2000 Holbrook MR, Li L, Suderman MT, Wang H, Barrett AD. The French neurotropic vaccine strain of yellow fever virus accumulates mutations slowly during passage in cell culture. Virus Research. 69: 31-9. PMID 10989183 DOI: 10.1016/S0168-1702(00)00168-4  0.718
2000 Wang E, Ni H, Xu R, Barrett AD, Watowich SJ, Gubler DJ, Weaver SC. Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses. Journal of Virology. 74: 3227-34. PMID 10708439 DOI: 10.1128/Jvi.74.7.3227-3234.2000  0.44
2000 Ni H, Ryman KD, Wang H, Saeed MF, Hull R, Wood D, Minor PD, Watowich SJ, Barrett AD. Interaction of yellow fever virus French neurotropic vaccine strain with monkey brain: characterization of monkey brain membrane receptor escape variants. Journal of Virology. 74: 2903-6. PMID 10684309 DOI: 10.1128/Jvi.74.6.2903-2906.2000  0.642
1999 Dunster LM, Wang H, Ryman KD, Miller BR, Watowich SJ, Minor PD, Barrett AD. Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus. Virology. 261: 309-18. PMID 10497116 DOI: 10.1006/Viro.1999.9873  0.557
1999 Monath TP, Soike K, Levenbook I, Zhang ZX, Arroyo J, Delagrave S, Myers G, Barrett AD, Shope RE, Ratterree M, Chambers TJ, Guirakhoo F. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates. Vaccine. 17: 1869-82. PMID 10217584 DOI: 10.1016/S0264-410X(98)00487-3  0.512
1999 Weaver SC, Powers AM, Brault AC, Barrett AD. Molecular epidemiological studies of veterinary arboviral encephalitides. Veterinary Journal (London, England : 1997). 157: 123-38. PMID 10204408 DOI: 10.1053/Tvjl.1998.0289  0.468
1998 Xie H, Ryman KD, Campbell GA, Barrett AD. Mutation in NS5 protein attenuates mouse neurovirulence of yellow fever 17D vaccine virus. The Journal of General Virology. 79: 1895-9. PMID 9714237 DOI: 10.1099/0022-1317-79-8-1895  0.441
1998 Ryman KD, Ledger TN, Campbell GA, Watowich SJ, Barrett AD. Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice. Virology. 244: 59-65. PMID 9581778 DOI: 10.1006/Viro.1998.9057  0.529
1997 Ryman KD, Ledger TN, Weir RC, Schlesinger JJ, Barrett AD. Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes. The Journal of General Virology. 78: 1353-6. PMID 9191929 DOI: 10.1099/0022-1317-78-6-1353  0.448
1997 Wang H, Jennings AD, Ryman KD, Late CM, Wang E, Ni H, Minor PD, Barrett AD. Genetic variation among strains of wild-type yellow fever virus from Senegal. The Journal of General Virology. 1349-52. PMID 9191928 DOI: 10.1099/0022-1317-78-6-1349  0.551
1997 Ryman KD, Xie H, Ledger TN, Campbell GA, Barrett AD. Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice. Virology. 230: 376-80. PMID 9143294 DOI: 10.1006/Viro.1997.8496  0.497
1995 Cao JX, Ni H, Wills MR, Campbell GA, Sil BK, Ryman KD, Kitchen I, Barrett AD. Passage of Japanese encephalitis virus in HeLa cells results in attenuation of virulence in mice. The Journal of General Virology. 76: 2757-64. PMID 7595383 DOI: 10.1099/0022-1317-76-11-2757  0.537
1995 Wang E, Ryman KD, Jennings AD, Wood DJ, Taffs F, Minor PD, Sanders PG, Barrett AD. Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine. The Journal of General Virology. 2749-55. PMID 7595382 DOI: 10.1099/0022-1317-76-11-2749  0.462
1993 Whitby JE, Whitby SN, Jennings AD, Stephenson JR, Barrett AD. Nucleotide sequence of the envelope protein of a Turkish isolate of tick-borne encephalitis (TBE) virus is distinct from other viruses of the TBE virus complex. The Journal of General Virology. 74: 921-4. PMID 8492100 DOI: 10.1099/0022-1317-74-5-921  0.522
1993 Jennings AD, Whitby JE, Minor PD, Barrett AD. Comparison of the nucleotide and deduced amino acid sequences of the envelope protein genes of the wild-type French viscerotropic strain of yellow fever virus and the live vaccine strain, French neurotropic vaccine, derived from it. Virology. 192: 692-5. PMID 8421909 DOI: 10.1006/Viro.1993.1090  0.491
1993 Whitby JE, Jennings AD, Barrett AD. Nucleotide sequence of the envelope protein gene of the tick-borne flavivirus, Kumlinge A52. Virus Genes. 7: 145-9. PMID 8367941 DOI: 10.1007/Bf01702394  0.454
1993 Wills MR, Singh BK, Debnath NC, Barrett AD. Immunogenicity of wild-type and vaccine strains of Japanese encephalitis virus and the effect of haplotype restriction on murine immune responses. Vaccine. 11: 761-6. PMID 8342323 DOI: 10.1016/0264-410X(93)90262-V  0.506
1993 Jennings AD, Whitby JE, Minor PD, Barrett AD. Comparison of the nucleotide and deduced amino acid sequences of the structural protein genes of the yellow fever 17DD vaccine strain from Senegal with those of other yellow fever vaccine viruses. Vaccine. 11: 679-81. PMID 8322493 DOI: 10.1016/0264-410X(93)90317-Q  0.443
1993 Whitby JE, Ni H, Whitby HE, Jennings AD, Bradley LM, Lee JM, Lloyd G, Stephenson JR, Barrett AD. Rapid detection of viruses of the tick-borne encephalitis virus complex by RT-PCR of viral RNA. Journal of Virological Methods. 45: 103-14. PMID 8270650 DOI: 10.1016/0166-0934(93)90144-G  0.416
1993 Fulop L, Barrett AD, Phillpotts R, Martin K, Leslie D, Titball RW. Rapid identification of flaviviruses based on conserved NS5 gene sequences. Journal of Virological Methods. 44: 179-88. PMID 8263114 DOI: 10.1016/0166-0934(93)90053-T  0.309
1992 Ledger TN, Sil BK, Dunster LM, Stephenson JR, Minor PD, Barrett AD. Yellow fever 17DD vaccine virus is temperature sensitive when grown in mosquito C6-36 cells. Vaccine. 10: 652-4. PMID 1523874 DOI: 10.1016/0264-410X(92)90084-W  0.379
1992 Ledger TN, Sil BK, Wills MR, Lewis G, Kinney RM, Jennings AD, Stephenson JR, Barrett AD. Variation in the biological function of envelope protein epitopes of yellow fever vaccine viruses detected with monoclonal antibodies. Biologicals : Journal of the International Association of Biological Standardization. 20: 117-28. PMID 1389107 DOI: 10.1016/S1045-1056(05)80059-4  0.469
1992 Paton DJ, Lowings JP, Barrett AD. Epitope mapping of the gp53 envelope protein of bovine viral diarrhea virus. Virology. 190: 763-72. PMID 1381537 DOI: 10.1016/0042-6822(92)90914-B  0.457
1992 Sil BK, Wills MR, Cao JX, Sharda R, Islam MA, Stagg DJ, Jennings AD, Gibson CA, Barrett AD. Immunogenicity of experimental live attenuated Japanese encephalitis vaccine viruses and comparison with wild-type strains using monoclonal and polyclonal antibodies. Vaccine. 10: 329-33. PMID 1315470 DOI: 10.1016/0264-410X(92)90372-Q  0.463
1992 Sil BK, Dunster LM, Ledger TN, Wills MR, Minor PD, Barrett AD. Identification of envelope protein epitopes that are important in the attenuation process of wild-type yellow fever virus. Journal of Virology. 66: 4265-4270. DOI: 10.1128/Jvi.66.7.4265-4270.1992  0.495
1991 Martins NR, Mockett AP, Barrett A, Cook JK. IgM responses in chicken serum to live and inactivated infectious bronchitis virus vaccines. Avian Diseases. 35: 470-475. DOI: 10.2307/1591209  0.459
1990 Barrett AD, Monath TP, Cropp CB, Adkins JA, Ledger TN, Gould EA, Schlesinger JJ, Kinney RM, Trent DW. Attenuation of wild-type yellow fever virus by passage in HeLa cells. The Journal of General Virology. 71: 2301-6. PMID 2230735 DOI: 10.1099/0022-1317-71-10-2301  0.503
1990 Gibson CA, Dunster LM, Bouloy M, Minor PD, Sanders PG, Barrett AD. Primer extension dideoxy chain termination nucleotide sequencing of partially purified RNA virus genomes: a technique for investigating low titre viruses with extensive genome secondary structure. Journal of Virological Methods. 29: 167-76. PMID 2176663 DOI: 10.1016/0166-0934(90)90110-2  0.349
1990 Dunster LM, Gibson CA, Stephenson JR, Minor PD, Barrett AD. Attenuation of virulence of flaviviruses following passage in HeLa cells. The Journal of General Virology. 71: 601-7. PMID 2155996 DOI: 10.1099/0022-1317-71-3-601  0.509
1990 Gibson CA, Wills MR, Gould EA, Sanders PG, Barrett AD. Effect of administration of sodium aurothiomalate on the virulence of yellow fever viruses in adult mice. Vaccine. 8: 590-4. PMID 2128429 DOI: 10.1016/0264-410X(90)90015-E  0.489
1990 Barrett AD, Mathews JH, Miller BR, Medlen AR, Ledger TN, Roehrig JT. Identification of monoclonal antibodies that distinguish between 17D-204 and other strains of yellow fever virus. The Journal of General Virology. 71: 13-8. PMID 1689367 DOI: 10.1099/0022-1317-71-1-13  0.526
1989 Barrett AD, Pryde A, Medlen AR, Ledger TN, Whitby JE, Gibson CA, DeSilva M, Groves DJ, Langley DJ, Minor PD. Examination of the envelope glycoprotein of yellow fever vaccine viruses with monoclonal antibodies. Vaccine. 7: 333-6. PMID 2479185 DOI: 10.1016/0264-410X(89)90196-5  0.437
1988 Gibson CA, Schlesinger JJ, Barrett AD. Prospects for a virus non-structural protein as a subunit vaccine. Vaccine. 6: 7-9. PMID 3281388 DOI: 10.1016/0264-410X(88)90004-7  0.414
1984 Barrett AD, Dimmock NJ. Properties of host and virus which influence defective interfering virus mediated-protection of mice against Semliki Forest virus lethal encephalitis. Brief report. Archives of Virology. 81: 185-8. PMID 6331348 DOI: 10.1007/Bf01309308  0.505
Show low-probability matches.